Navigation Links
New Pathways Studied to Repair Nerves
Date:11/6/2008

Two different approaches seek to interfere with mechanisms that inhibit cell regeneration

THURSDAY, Nov. 6 (HealthDay News) -- Nerve cells in the spinal cord and brain can't be repaired now if they are severed or damaged, but two ways to get them to grow again are being proposed by separate groups of researchers.

The basic idea of both approaches is to interfere with the built-in mechanisms that prevent nerve cell regeneration. One approach attacks it from the outside of nerve cells, the other from the inside.

Zhigang He, an associate professor of neurology at Children's Hospital Boston, a teaching affiliate of Harvard University, compared the two approaches to different ways of starting a stalled auto.

"Their idea is that something is blocking the highway," said He, lead author of one of the two papers in the Nov. 7 issue of Science. "Our mechanism deals with possible engine trouble."

Growth controls are built into the genes of nerve cells, He said. His group has identified two of the key genes that inhibit the major growth pathway in nerve cells. When those two genes are knocked out, cells that are damaged or severed can grow new axons, the pathways that carry messages from cell to cell.

A study in which mice whose optic nerves were damaged showed up to 50 percent of those cells engineered to lack the two growth-inhibiting genes survived, compared to 20 percent of the cells carrying those genes. Significant axon growth was seen in up to 10 percent of the mice lacking the genes.

Genetic engineering is not necessary to achieve that kind of nerve growth, He said. "In the future, we could have small-molecule drugs to activate these pathways," He said. "Other people have studied this pathway already, and there are quite a few possible targets."

He's group has started to work with some candidate compounds. "It's too early to say if these compounds would be effective," he said. "We don't know about toxicity, that sort of thing. We have lots of work to do."

A second paper by researchers at the San Francisco-based biotechnology company Genentech looked at the growth-preventing mechanism built into myelin, the protective sheath that surrounds nerve cells. They have identified a previously unknown receptor for the growth-preventing molecules in myelin. Block that receptor, and growth can be restored, said Marc Tessier-Lavigne, executive vice president of research drug discovery at Genentech.

"This is a mechanism we can try to target," Tessier-Lavigne said. The paper describes a molecule that has blocked the receptor in mice. "Now we are working on a human protein."

Both approaches require more work, said Dr. William D. Snider, director of the University of North Carolina Neurosciences Institute, and co-author of an accompanying editorial.

The idea of blocking growth-preventing genes "is a very clever way of restoring normal levels of proteins," Snider said, but he was cautious, because all the work reported in the paper was done in mice.

"Mice are extremely small animals when you compare their nervous systems to humans," Snider said. "Work in primates might be more relevant. Those of us who have been in the field for a while are extremely cautious about extrapolating from mice."

The Genentech myelin approach is not new, Snider noted. "People have known in general that myelin down-regulates nerve cell growth capacity, although they're not certain why that is true," he said. One belief is that the myelin mechanism is designed to prevent errors at times when there is a major change in the central nervous system. Knowledge of a new receptor that governs nerve cell growth could be of practical value, Snider said.

More information

The workings of nerve cells are explained by the U.S. National Institute of Neurological Disorders and Stroke.



SOURCES: Zhigang He, Ph.D., associate professor, neurology, Children's Hospital Boston; Marc Tessier-Lavigne, Ph.D., executive vice president, research drug discovery, Genentech Inc., South San Francisco; William D. Snider, M.D., director, University of North Carolina Neurosciences Institute, Chapel Hill; Nov. 7, 2008, Science


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Embryonic Pathways Induce Stem Cell Traits
2. Breast cancer subtypes originate from different biological pathways
3. Stem Cell Marker Controls Pair of Key Cancer Pathways
4. Georgetown researchers find stem cell marker controls 2 key cancer pathways
5. Different Neural Pathways at Work Going Under, Coming Out of Anesthesia
6. Post-partum suicide attempt risks studied
7. Fish oil and red yeast rice studied for lowering blood cholesterol
8. Effects of healing touch therapy being studied
9. No difference in sleep of OSA patients studied in a hospital vs. a hotel-based sleep center
10. Eltrombopag studied in Idiopathic Thrombocytopenic Purpura
11. New treatment option studied for bladder cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Pathways Studied to Repair Nerves
(Date:2/27/2017)... ... February 27, 2017 , ... Much attention has been paid to the problem ... on opioid painkillers has fallen short. From 1999 until 2010, fatal overdoses from prescription ... fatal overdoses in male populations.(1) , The proportion of women using illicit drugs is ...
(Date:2/27/2017)... ... 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. She went from working ... nun. Now, she writes about God, when she isn’t swimming as a performing mermaid. , ... is BS! (Before Satan),” she offers a comedic look at the dysfunctions of God’s family, ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
(Date:2/27/2017)... POUGHKEEPSIE, N. Y. (PRWEB) , ... February 27, 2017 , ... ... Society ( ILADS ) has disclosed that despite scientific studies, the Center for Disease ... of chronic Lyme disease . Kenneth B. Liegner, M.D. has compiled into ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , is ... team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation in ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... --  Fourth-quarter 2016 revenues of ... to top end of guidance ... in fourth-quarter 2016 associated with the write-down of goodwill ... reporting unit Fourth-quarter reported ... Full-year 2016 reported $14.48 diluted (GAAP) loss per share ...
(Date:2/27/2017)... 27, 2017 Mederi Therapeutics today announced ... representing 2468 patients who received  Stretta Therapy  to ... " Systematic Review and Meta-Analysis of Controlled and ... Treatment of Gastroesophageal Reflux Disease ", was published in ... Fass , MD, head of the Esophageal and ...
(Date:2/27/2017)... Feb. 27, 2017   Vitasome ® Labs ... supplements using its groundbreaking new liposome technology. Whereas vitamins ... potency through digestion per Physician,s Desk Reference , ... problem of nutritional waste and are scientifically formulated to: ... processes Improve bioavailability with a vastly ...
Breaking Medicine Technology: